Document is current
Any future updates will be listed below
-
Authors
Tibble, Holly https://orcid.org/0000-0001-7169-4087
Mueller, Tanja https://orcid.org/0000-0002-0418-4789
Proud, Euan
Hall, Elliott
Kurdi, Amanj
Robertson, Chris https://orcid.org/0000-0001-6848-5241
Bennie, Marion
Woolford, Lana
Laidlaw, Lynn
Sterniczuk, Kamil
Sheikh, Aziz
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (UKRIMC_PC19075)
DH | National Institute for Health Research (NIHR135575)
- License Information
-
More Information
Article History
Received: 27 April 2023
Accepted: 12 June 2024
First Online: 28 June 2024
Competing interests
: AS has served on COVID-19 Advisory Groups for the UK and Scottish Governments and AstraZeneca, all of which have been unremunerated. He holds a research grant on the effectiveness and safety of mABs from GSK. AS has served on a number of UK and Scottish Government COVID-19 advisory bodies and is former Editor-in-Chief of npj PCRM.
: Data approvals were obtained from the National Research Ethics Service Committee, Southeast Scotland 02 (reference number: 12/SS/0201), and Public Benefit and Privacy Panel for Health and Social Care (reference number: 0920-0279).
